This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matsushita, S Articles by Putney, S Search for Related Content PubMed PubMed Citation Articles by Matsushita, S Articles by Putney, S

 Previous Article  |  Next Article 

J Virol. 1988 June; 62(6): 2107-2114

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope.

Second Department of Internal Medicine, Kumamoto University Medical School, Japan.

ABSTRACT

A monoclonal antibody was produced to the exterior envelope glycoprotein (gp120) of the human T-cell lymphotropic virus (HTLV)-IIIB isolate of the human immunodeficiency virus (HIV). This antibody binds to gp120 of HTLV-IIIB and lymphadenopathy-associated virus type 1 (LAV-1) and to the surface of HTLV-IIIB- and LAV-1-infected cells, neutralizes infection by cell-free virus, and prevents fusion of virus-infected cells. In contrast, it does not bind, or weakly binds, the envelope of four heterologous HIV isolates and does not neutralize heterologous isolates HTLV-IIIRF and HTLV-IIIMN. The antibody-binding site was mapped to a 24-amino-acid segment, using recombinant and synthetic segments of HTLV-IIIB gp120. This site is within a segment of amino acid variability known to contain the major neutralizing epitopes (S. D. Putney, T. J. Matthews, W. G. Robey, D. L. Lynn, M. Robert-Guroff, W. T. Mueller, A. J. Langlois, J. Ghrayeb, S. R. Petteway, K. J. Weinhold, P. J. Fischinger, F. Wong-Staal, R. C. Gallo, and D. P. Bolognesi, Science 234:1392-1395, 1986). These results localize an epitope of HIV type-specific neutralization and suggest that neutralizing antibodies may be effective in controlling cell-associated, as well as cell-free, virus infection.

This article has been cited by other articles:

• Ansari, I. H., Kwon, B., Osorio, F. A., Pattnaik, A. K. (2006). Influence of N-Linked Glycosylation of Porcine Reproductive and Respiratory Syndrome Virus GP5 on Virus Infectivity, Antigenicity, and Ability To Induce Neutralizing Antibodies.. J. Virol. 80: 3994-4004 [Abstract] [Full Text]  
• Jinno-Oue, A., Shimizu, N., Soda, Y., Tanaka, A., Ohtsuki, T., Kurosaki, D., Suzuki, Y., Hoshino, H. (2005). The Synthetic Peptide Derived from the NH2-terminal Extracellular Region of an Orphan G Protein-coupled Receptor, GPR1, Preferentially Inhibits Infection of X4 HIV-1. J. Biol. Chem. 280: 30924-30934 [Abstract] [Full Text]  
• Leavitt, M., Park, E. J., Sidorov, I. A., Dimitrov, D. S., Quinnan, G. V. Jr. (2002). Concordant Modulation of Neutralization Resistance and High Infectivity of the Primary Human Immunodeficiency Virus Type 1 MN Strain and Definition of a Potential gp41 Binding Site in gp120. J. Virol. 77: 560-570 [Abstract] [Full Text]  
• Jeetendra, E., Robison, C. S., Albritton, L. M., Whitt, M. A. (2002). The Membrane-Proximal Domain of Vesicular Stomatitis Virus G Protein Functions as a Membrane Fusion Potentiator and Can Induce Hemifusion. J. Virol. 76: 12300-12311 [Abstract] [Full Text]  
• Quinones-Kochs, M. I., Buonocore, L., Rose, J. K. (2002). Role of N-Linked Glycans in a Human Immunodeficiency Virus Envelope Glycoprotein: Effects on Protein Function and the Neutralizing Antibody Response. J. Virol. 76: 4199-4211 [Abstract] [Full Text]  
• Hirota, K., Nagata, K., Norose, Y., Futagami, S., Nakagawa, Y., Senpuku, H., Kobayashi, M., Takahashi, H. (2001). Identification of an Antigenic Epitope in Helicobacter pylori Urease That Induces Neutralizing Antibody Production. Infect. Immun. 69: 6597-6603 [Abstract] [Full Text]  
• Sakai, T., Matsuoka, M., Aoki, M., Nosaka, K., Mitsuya, H. (2001). Missense mutation of the interleukin-12 receptor {beta}1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. Blood 97: 2688-2694 [Abstract] [Full Text]  
• Cho, M. W., Kim, Y. B., Lee, M. K., Gupta, K. C., Ross, W., Plishka, R., Buckler-White, A., Igarashi, T., Theodore, T., Byrum, R., Kemp, C., Montefiori, D. C., Martin, M. A. (2001). Polyvalent Envelope Glycoprotein Vaccine Elicits a Broader Neutralizing Antibody Response but Is Unable To Provide Sterilizing Protection against Heterologous Simian/Human Immunodeficiency Virus Infection in Pigtailed Macaques. J. Virol. 75: 2224-2234 [Abstract] [Full Text]  
• Etemad-Moghadam, B., Sun, Y., Nicholson, E. K., Karlsson, G. B., Schenten, D., Sodroski, J. (1999). Determinants of Neutralization Resistance in the Envelope Glycoproteins of a Simian-Human Immunodeficiency Virus Passaged In Vivo. J. Virol. 73: 8873-8879 [Abstract] [Full Text]  
• Buge, S. L., Murty, L., Arora, K., Kalyanaraman, V. S., Markham, P. D., Richardson, E. S., Aldrich, K., Patterson, L. J., Miller, C. J., Cheng, S.-M., Robert-Guroff, M. (1999). Factors Associated with Slow Disease Progression in Macaques Immunized with an Adenovirus-Simian Immunodeficiency Virus (SIV) Envelope Priming-gp120 Boosting Regimen and Challenged Vaginally with SIVmac251. J. Virol. 73: 7430-7440 [Abstract] [Full Text]  
• Shimizu, N., Soda, Y., Kanbe, K., Liu, H.-Y., Jinno, A., Kitamura, T., Hoshino, H. (1999). An Orphan G Protein-Coupled Receptor, GPR1, Acts as a Coreceptor To Allow Replication of Human Immunodeficiency Virus Types 1 and 2 in Brain-Derived Cells. J. Virol. 73: 5231-5239 [Abstract] [Full Text]  
• Wu, X., Okada, N., Momota, H., Irie, R. F., Okada, H. (1999). Complement-Mediated Anti-HIV-1 Effect Induced by Human IgM Monoclonal Antibody Against Ganglioside GM2. J. Immunol. 162: 533-539 [Abstract] [Full Text]  
• Sakaida, H., Hori, T., Yonezawa, A., Sato, A., Isaka, Y., Yoshie, O., Hattori, T., Uchiyama, T. (1998). T-Tropic Human Immunodeficiency Virus Type 1 (HIV-1)-Derived V3 Loop Peptides Directly Bind to CXCR-4 and Inhibit T-Tropic HIV-1 Infection. J. Virol. 72: 9763-9770 [Abstract] [Full Text]  
• Etemad-Moghadam, B., Karlsson, G. B., Halloran, M., Sun, Y., Schenten, D., Fernandes, M., Letvin, N. L., Sodroski, J. (1998). Characterization of Simian-Human Immunodeficiency Virus Envelope Glycoprotein Epitopes Recognized by Neutralizing Antibodies from Infected Monkeys. J. Virol. 72: 8437-8445 [Abstract] [Full Text]  
• Park, E. J., Vujcic, L. K., Anand, R., Theodore, T. S., Quinnan, G. V. Jr. (1998). Mutations in both gp120 and gp41 Are Responsible for the Broad Neutralization Resistance of Variant Human Immunodeficiency Virus Type 1 MN to Antibodies Directed at V3 and Non-V3 Epitopes. J. Virol. 72: 7099-7107 [Abstract] [Full Text]  
• Ishikawa, H., Sasaki, M., Noda, S., Koga, Y. (1998). Apoptosis Induction by the Binding of the Carboxyl Terminus of Human Immunodeficiency Virus Type 1 gp160 to Calmodulin. J. Virol. 72: 6574-6580 [Abstract] [Full Text]  
• D'Aloja, P., Olivetta, E., Bona, R., Nappi, F., Pedacchia, D., Pugliese, K., Ferrari, G., Verani, P., Federico, M. (1998). gag, vif, and nef Genes Contribute to the Homologous Viral Interference Induced by a Nonproducer Human Immunodeficiency Virus Type 1 (HIV-1) Variant: Identification of Novel HIV-1-Inhibiting Viral Protein Mutants. J. Virol. 72: 4308-4319 [Abstract] [Full Text]  
• Okamoto, Y., Eda, Y., Ogura, A., Shibata, S., Amagai, T., Katsura, Y., Asano, T., Kimachi, K., Makizumi, K., Honda, M. (1998). In SCID-hu Mice, Passive Transfer of a Humanized Antibody Prevents Infection and Atrophic Change of Medulla in Human Thymic Implant due to Intravenous Inoculation of Primary HIV-1 Isolate. J. Immunol. 160: 69-76 [Abstract] [Full Text]  
• Faiman, G. A., Horovitz, A. (1997). Thermodynamic Analysis of the Interaction between the 0.5beta Fv Fragment and the RP135 Peptide Antigen Derived from the V3 Loop of HIV-1 gp120. J. Biol. Chem. 272: 31407-31411 [Abstract] [Full Text]  
• Faiman, G. A., Levy, R., Anglister, J., Horovitz, A. (1996). Contribution of Arginine Residues in the RP135 Peptide Derived from the V3 Loop of gp120 to Its Interaction with the Fv Fragment of the 0.5beta HIV-1 Neutralizing Antibody. J. Biol. Chem. 271: 13829-13833 [Abstract] [Full Text]  
• Freed, E. O., Martin, M. A. (1995). The Role of Human Immunodeficiency Virus Type 1 Envelope Glycoproteins in Virus Infection. J. Biol. Chem. 270: 23883-23886 [Full Text]  
• Wain-Hobson, S, Vartanian, J., Henry, M, Chenciner, N, Cheynier, R, Delassus, S, Martins, L., Sala, M, Nugeyre, M., Guetard, D, et, al. (1991). LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur. Science 252: 961-965 [Abstract]  
• Javaherian, K, Langlois, A., LaRosa, G., Profy, A., Bolognesi, D., Herlihy, W., Putney, S., Matthews, T. (1990). Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science 250: 1590-1593 [Abstract]  
• Mitsuya, H, Yarchoan, R, Broder, S (1990). Molecular targets for AIDS therapy. Science 249: 1533-1544 [Abstract]  
• LaRosa, G., Davide, J., Weinhold, K, Waterbury, J., Profy, A., Lewis, J., Langlois, A., Dreesman, G., Boswell, R., Shadduck, P, et, al. (1990). Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249: 932-935 [Abstract]  
• Looney, D., Fisher, A., Putney, S., Rusche, JR, Redfield, R., Burke, D., Gallo, R., Wong-Staal, F (1988). Type-restricted neutralization of molecular clones of human immunodeficiency virus. Science 241: 357-359 [Abstract]